Leah Rand
@leah-rand.bsky.social
Research Scientist at the Program on Regulation, Therapeutics, and Law @portalresearch.org and Lecturer, Harvard Medical School
Interests: prescription drugs, bioethics, health technology assessment, and justice
Interests: prescription drugs, bioethics, health technology assessment, and justice
Reposted by Leah Rand
Virginia senators on news state ACA insurance premiums will rise an average 20.5%:
"While President Trump and congressional Republicans bent over backward to extend tax cuts for the uber-wealthy as part of their tax and budget bill, they chose not to renew these critical healthcare credits."
"While President Trump and congressional Republicans bent over backward to extend tax cuts for the uber-wealthy as part of their tax and budget bill, they chose not to renew these critical healthcare credits."
August 8, 2025 at 9:00 PM
Virginia senators on news state ACA insurance premiums will rise an average 20.5%:
"While President Trump and congressional Republicans bent over backward to extend tax cuts for the uber-wealthy as part of their tax and budget bill, they chose not to renew these critical healthcare credits."
"While President Trump and congressional Republicans bent over backward to extend tax cuts for the uber-wealthy as part of their tax and budget bill, they chose not to renew these critical healthcare credits."
Reposted by Leah Rand
New @healthaffairs.bsky.social paper on how CMS can integrate formal aspects of #HTA, much of which is patterned after @icer-review.bsky.social practices! Many thanks to @commonwealthfund.org for their support. @basucally.bsky.social @leah-rand.bsky.social
www.healthaffairs.org/doi/10.1377/...
www.healthaffairs.org/doi/10.1377/...
Health Technology Assessment, Again: A Transparent, Evidence-Based Approach For CMS Drug Price Negotiations | Health Affairs Journal
The Centers for Medicare and Medicaid Services (CMS) can now negotiate the prices of a set of drugs that represent significant Medicare expenditures. The long-term success of negotiations will depend ...
www.healthaffairs.org
August 4, 2025 at 9:09 PM
New @healthaffairs.bsky.social paper on how CMS can integrate formal aspects of #HTA, much of which is patterned after @icer-review.bsky.social practices! Many thanks to @commonwealthfund.org for their support. @basucally.bsky.social @leah-rand.bsky.social
www.healthaffairs.org/doi/10.1377/...
www.healthaffairs.org/doi/10.1377/...
Reposted by Leah Rand
New on FirstView: "Impostor Syndrome: Fraudulent Participants in Qualitative Research Can Skew Results" by @leah-rand.bsky.social, @akesselheim.bsky.social of @portalresearch.org & coauthors offers actionable ways to overcome the fraudulent participant problem.
www.cambridge.org/core/journal...
www.cambridge.org/core/journal...
![Impostor Syndrome: Fraudulent Participants in Qualitative Research Can Skew Results
Published online by Cambridge University Press: 07 July 2025
Leah Z. Rand
Open the ORCID record for Leah Z. Rand[Opens in a new window]
,
Sarah McGraw
,
Junyi Wang
,
Jonathan J. Darrow
and
Aaron S. Kesselheim
Abstract
We report on an experience with impostor research participants, people who misrepresent themselves, and identify characteristics that can be used by investigators to screen out such participants. We compare the responses of impostor and valid participants, showing that impostors meaningfully change qualitative study findings with implications for policy interventions or follow-on research informed by the study. It is important for investigators to be alert to the potential for impostor participants and plan their research accordingly.](https://cdn.bsky.app/img/feed_thumbnail/plain/did:plc:lhh5nilokympq5kvbck6qjwl/bafkreidwgxg5eg6sjgs2ah4uozxjcbxdjmv7ijzjtccdjucd5fpdgeae5e@jpeg)
July 10, 2025 at 6:26 PM
New on FirstView: "Impostor Syndrome: Fraudulent Participants in Qualitative Research Can Skew Results" by @leah-rand.bsky.social, @akesselheim.bsky.social of @portalresearch.org & coauthors offers actionable ways to overcome the fraudulent participant problem.
www.cambridge.org/core/journal...
www.cambridge.org/core/journal...
Reposted by Leah Rand
Medicaid is the backbone of health coverage in Kentucky - and that is by far its most important role.
Often unlooked, however, is the substantial role it plays in our economy. Through the care it pays for, jobs are created, workers supported, and economic activity is generated.
Often unlooked, however, is the substantial role it plays in our economy. Through the care it pays for, jobs are created, workers supported, and economic activity is generated.
May 6, 2025 at 7:59 PM
Medicaid is the backbone of health coverage in Kentucky - and that is by far its most important role.
Often unlooked, however, is the substantial role it plays in our economy. Through the care it pays for, jobs are created, workers supported, and economic activity is generated.
Often unlooked, however, is the substantial role it plays in our economy. Through the care it pays for, jobs are created, workers supported, and economic activity is generated.
Reposted by Leah Rand
Out today!
The latest in the series "Around the World in HTAs" from the OHE (@ohenews.bsky.social) is an overview of the Canadian process that I wrote with Chris Skedgel (@chrissked.bsky.social).
If you need a general overview of the HTA process in Canada, check it out!
www.ohe.org/insight/arou...
The latest in the series "Around the World in HTAs" from the OHE (@ohenews.bsky.social) is an overview of the Canadian process that I wrote with Chris Skedgel (@chrissked.bsky.social).
If you need a general overview of the HTA process in Canada, check it out!
www.ohe.org/insight/arou...
Around the World in HTAs: Canada – Autonomous yet Collaborative - OHE
In this Insights series, Around the World in HTAs, we shed light on HTA around the world. In this edition, Adam Raymakers and Chris Skedgel take us to Canada.
www.ohe.org
April 9, 2025 at 1:13 PM
Out today!
The latest in the series "Around the World in HTAs" from the OHE (@ohenews.bsky.social) is an overview of the Canadian process that I wrote with Chris Skedgel (@chrissked.bsky.social).
If you need a general overview of the HTA process in Canada, check it out!
www.ohe.org/insight/arou...
The latest in the series "Around the World in HTAs" from the OHE (@ohenews.bsky.social) is an overview of the Canadian process that I wrote with Chris Skedgel (@chrissked.bsky.social).
If you need a general overview of the HTA process in Canada, check it out!
www.ohe.org/insight/arou...
Reposted by Leah Rand
WATCH: @akesselheim.bsky.social testifies before @waysmeanscmte.bsky.social
On NIH cuts - "...the next generation will look back at this moment & ask what we were doing while the Trump administration systematically disposed of 1000s of research projects that could've helped patients."
On NIH cuts - "...the next generation will look back at this moment & ask what we were doing while the Trump administration systematically disposed of 1000s of research projects that could've helped patients."
April 9, 2025 at 1:57 PM
WATCH: @akesselheim.bsky.social testifies before @waysmeanscmte.bsky.social
On NIH cuts - "...the next generation will look back at this moment & ask what we were doing while the Trump administration systematically disposed of 1000s of research projects that could've helped patients."
On NIH cuts - "...the next generation will look back at this moment & ask what we were doing while the Trump administration systematically disposed of 1000s of research projects that could've helped patients."
Reposted by Leah Rand
Check out the latest research from the PORTAL team in the April edition of our newsletter, featuring analysis on generic drug 'skinny labeling,' the expansion of the 340B program, a new form of product hopping, and much more! 🛟🧪
mailchi.mp/57ccd5e0b342...
mailchi.mp/57ccd5e0b342...
PORTAL Post | April 2025
Skinny labeling, 340B expansion, patent games, and more analysis from the PORTAL team.
mailchi.mp
April 3, 2025 at 2:11 PM
Check out the latest research from the PORTAL team in the April edition of our newsletter, featuring analysis on generic drug 'skinny labeling,' the expansion of the 340B program, a new form of product hopping, and much more! 🛟🧪
mailchi.mp/57ccd5e0b342...
mailchi.mp/57ccd5e0b342...
Reposted by Leah Rand
The speed with which we are going backwards is beyond unsettling. Without public discourse, without debate, without Congressional input, without investigation into the impact and effect of these changes for the country ... www.bloomberg.com/opinion/feat...
March 27, 2025 at 9:38 PM
The speed with which we are going backwards is beyond unsettling. Without public discourse, without debate, without Congressional input, without investigation into the impact and effect of these changes for the country ... www.bloomberg.com/opinion/feat...
Reposted by Leah Rand
Each admin gets to put its own stamp on science funding priorities (w/ caveats around rigor, not using science $ to wage other political battles). One admin's priorities extend into the next and so on. But science cannot work if you burn it down every 4 years.
www.washingtonpost.com/politics/202...
www.washingtonpost.com/politics/202...
Trump promised scientific breakthroughs. Researchers say he’s breaking science.
NIH funding for biomedical research has abruptly fallen by billions of dollars, with many grant decisions on hold. Trump officials say they’re reviewing the agency.
www.washingtonpost.com
March 28, 2025 at 4:58 PM
Each admin gets to put its own stamp on science funding priorities (w/ caveats around rigor, not using science $ to wage other political battles). One admin's priorities extend into the next and so on. But science cannot work if you burn it down every 4 years.
www.washingtonpost.com/politics/202...
www.washingtonpost.com/politics/202...
Reposted by Leah Rand
Nice piece by @peterneumann11.bsky.social showing how US-based CEAs continue to use QALYs as an outcome, despite the opposition of some.
cevr.tuftsmedicalcenter.org/news/the-dea...
cevr.tuftsmedicalcenter.org/news/the-dea...
The Death of QALYs is Greatly Exaggerated - Center for the Evaluation of Value and Risk in Health
cevr.tuftsmedicalcenter.org
March 22, 2025 at 5:08 PM
Nice piece by @peterneumann11.bsky.social showing how US-based CEAs continue to use QALYs as an outcome, despite the opposition of some.
cevr.tuftsmedicalcenter.org/news/the-dea...
cevr.tuftsmedicalcenter.org/news/the-dea...
Join us tomorrow for a discussion of private equity in health care and policy solutions to protect patients and care quality
Friday, FEB 7 12:30-1:30 pm on Zoom
Register: lp.constantcontactpages.com/ev/reg/x422s...
@harvardchanschool.bsky.social @petrieflomcenter.bsky.social @portalresearch.org
Friday, FEB 7 12:30-1:30 pm on Zoom
Register: lp.constantcontactpages.com/ev/reg/x422s...
@harvardchanschool.bsky.social @petrieflomcenter.bsky.social @portalresearch.org
February 6, 2025 at 9:12 PM
Join us tomorrow for a discussion of private equity in health care and policy solutions to protect patients and care quality
Friday, FEB 7 12:30-1:30 pm on Zoom
Register: lp.constantcontactpages.com/ev/reg/x422s...
@harvardchanschool.bsky.social @petrieflomcenter.bsky.social @portalresearch.org
Friday, FEB 7 12:30-1:30 pm on Zoom
Register: lp.constantcontactpages.com/ev/reg/x422s...
@harvardchanschool.bsky.social @petrieflomcenter.bsky.social @portalresearch.org
Reposted by Leah Rand
🚨 Just out today (online)! 🚨
Our results show that a common argument against #QALYs (based on the use of subgroup analyses) is not justified with empirical data.
With co-authors: @leah-rand.bsky.social , @wbfeldman.bsky.social, & @akesselheim.bsky.social from @portalresearch.org.
Our results show that a common argument against #QALYs (based on the use of subgroup analyses) is not justified with empirical data.
With co-authors: @leah-rand.bsky.social , @wbfeldman.bsky.social, & @akesselheim.bsky.social from @portalresearch.org.
January 31, 2025 at 8:11 PM
🚨 Just out today (online)! 🚨
Our results show that a common argument against #QALYs (based on the use of subgroup analyses) is not justified with empirical data.
With co-authors: @leah-rand.bsky.social , @wbfeldman.bsky.social, & @akesselheim.bsky.social from @portalresearch.org.
Our results show that a common argument against #QALYs (based on the use of subgroup analyses) is not justified with empirical data.
With co-authors: @leah-rand.bsky.social , @wbfeldman.bsky.social, & @akesselheim.bsky.social from @portalresearch.org.
Reposted by Leah Rand
opportunity costs associated with NICE recommendations.
Defo the most important h economics paper you will read today, maybe this week, maybe the year so far
This is where the primary care budget gets spent
A
www.thelancet.com/journals/lan...
Defo the most important h economics paper you will read today, maybe this week, maybe the year so far
This is where the primary care budget gets spent
A
www.thelancet.com/journals/lan...
December 13, 2024 at 6:30 PM
opportunity costs associated with NICE recommendations.
Defo the most important h economics paper you will read today, maybe this week, maybe the year so far
This is where the primary care budget gets spent
A
www.thelancet.com/journals/lan...
Defo the most important h economics paper you will read today, maybe this week, maybe the year so far
This is where the primary care budget gets spent
A
www.thelancet.com/journals/lan...
Reposted by Leah Rand
Check out the latest research from PORTAL in the December edition of our monthly newsletter! Featuring analyses on vaccine hesitancy, patent thickets, march-in rights, antibiotic prescribing and more. Sign up here: eepurl.com/iQSXmU
PORTAL Post | December 2024
Vaccine hesitency, biologics vs. small molecules, clearing patent thickets, technology transfer, and more from the PORTAL research team.
mailchi.mp
December 5, 2024 at 3:15 PM
Check out the latest research from PORTAL in the December edition of our monthly newsletter! Featuring analyses on vaccine hesitancy, patent thickets, march-in rights, antibiotic prescribing and more. Sign up here: eepurl.com/iQSXmU
Reposted by Leah Rand
📣PORTAL is hiring! 📣
There are less than 2 weeks left to apply for our Postdoctoral and General Medicine Fellowships, both with a focus on pharmaceutical law, health policy, and health services research. Apply by December 1, 2024.
Learn more: mailchi.mp/3e02f38a708b/portal-hiring-2025
There are less than 2 weeks left to apply for our Postdoctoral and General Medicine Fellowships, both with a focus on pharmaceutical law, health policy, and health services research. Apply by December 1, 2024.
Learn more: mailchi.mp/3e02f38a708b/portal-hiring-2025
Deadline Approaching - Join the PORTAL Team!
Apply by December 1, 2024 to be a PORTAL Postdoctoral or General Medicine Fellow. We are also accepting applications for a Faculty Member in Health Policy or Health Services Research.
mailchi.mp
November 21, 2024 at 5:31 PM
📣PORTAL is hiring! 📣
There are less than 2 weeks left to apply for our Postdoctoral and General Medicine Fellowships, both with a focus on pharmaceutical law, health policy, and health services research. Apply by December 1, 2024.
Learn more: mailchi.mp/3e02f38a708b/portal-hiring-2025
There are less than 2 weeks left to apply for our Postdoctoral and General Medicine Fellowships, both with a focus on pharmaceutical law, health policy, and health services research. Apply by December 1, 2024.
Learn more: mailchi.mp/3e02f38a708b/portal-hiring-2025